igf-1 lr3 100mcg vial 100 mcg (10 Vials) at ₹ 11000/box in Nagpur Thaiger IGF-1 LR3 100mcg Injection
Description
10.1002/fsn3.70101 24
Based on these data, an ongoing phase 1/2a, multicenter, open-label, ascending dose, first in-human clinical trial is planned to evaluate the safety of intracisternal PR001A (AAV9-GBA1) administration in patients with moderate to severe PD with at least one GBA pathogenic variant (NCT04127578, Table 2)
Sm t n h tr tng ham mun, gim kh hn
Relative abundance of megamonas hypermegale and butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with behcet's disease (210 characters)
doi: 10.1074/jbc.M405127200
